Cargando…
Severe Adverse Toxic Effects of Low-Dose Methotrexate Treatment on an Ectopic Pregnancy Patient With Methylenetetrahydrofolate Reductase Mutations: A Case Report
Background: Low-dose methylenetetrahydrofolate (LD-MTX) has been widely used for the treatment of the ectopic pregnancy (EP) for many decades, and related severe adverse toxic effects are rare. Current studies have shown that the polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene can...
Autores principales: | Yu, Huan, Wang, Wenhui, Liang, Haiyan, Wang, Kun, Ling, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636773/ https://www.ncbi.nlm.nih.gov/pubmed/34869432 http://dx.doi.org/10.3389/fmed.2021.738315 |
Ejemplares similares
-
Relationship between methylenetetrahydrofolate reductase gene polymorphisms and methotrexate drug metabolism and toxicity
por: Tan, Yinli, et al.
Publicado: (2023) -
Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome
por: Turgal, Mert, et al.
Publicado: (2018) -
The role of ultrasonography in methotrexate therapy for ectopic pregnancy
por: Czuczwar, Piotr
Publicado: (2018) -
Influence of Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphism on High-Dose Methotrexate-Related Toxicities in Pediatric Non-Hodgkin Lymphoma Patients
por: Lu, Suying, et al.
Publicado: (2021) -
Contribution of genetic polymorphism of methylene tetrahydrofolate reductase on the effect of methotrexate in ectopic pregnancy patients
por: Deng, Jie, et al.
Publicado: (2019)